Page 1 of Clinical Trials for Zometa, 239 Total Matches
- 1CompletedLast Updated: March 23, 2012Condition(s): Giant Cell Tumors of Bone
- 2Active, not recruitingLast Updated: February 3, 2010Condition(s): Prostate Cancer
- 3RecruitingLast Updated: October 6, 2011Condition(s): Adenocarcinoma
- 4Active, not recruitingLast Updated: January 30, 2012Condition(s): Breast Cancer
- 5TerminatedLast Updated: April 30, 2012Condition(s): Prostate Cancer
- 6CompletedLast Updated: September 13, 2010Condition(s): Metastatic Breast Cancer; Bone Metastases
- 7CompletedLast Updated: March 4, 2012Condition(s): Nasopharyngeal Cancer
- 8CompletedLast Updated: March 22, 2012Condition(s): Multiple Myeloma; Breast Cancer
- 9RecruitingLast Updated: November 1, 2011Condition(s): Prostate Cancer
- 10CompletedLast Updated: April 27, 2012Condition(s): Bone Loss; Prostate Cancer
- 11TerminatedLast Updated: July 26, 2011Condition(s): Malignant Pleural Effusion; Non Small Cell Lung Cancer
- 12Not yet recruitingLast Updated: February 8, 2012Condition(s): Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer; Invasive Ductal Breast Carcinoma; Progesterone Receptor-negative Breast Cancer; Progesterone Receptor-positive Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer
- 13RecruitingLast Updated: May 23, 2012Condition(s): Mesothelioma
- 14CompletedLast Updated: May 1, 2012Condition(s): Paget's Disease of the Bone
- 15CompletedLast Updated: March 23, 2011Condition(s): Osteoporosis
- 16Active, not recruitingLast Updated: March 12, 2012Condition(s): First or Second Line HER2-negative Breast Cancer; Metastatic Disease Without Bone Metastasis
- 17CompletedLast Updated: March 19, 2012Condition(s): Breast Cancer
- 18CompletedLast Updated: September 16, 2011Condition(s): Non-Hodgkin's Lymphoma; Lymphoma
- 19CompletedLast Updated: May 7, 2010Condition(s): Prostate Cancer; Adenocarcinoma of the Prostate
- 20RecruitingLast Updated: December 29, 2011Condition(s): Locally Advanced Breast Cancer; Ductal Histologic Type; Without Her2 Overexpression.
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Zometa
